Coronavirus Disease Olfactory Dysfunction: A Randomized Controlled Trial


Alex Zxi Jian Ho • Nur Izzati B. Ishak • Eugene Hung Chih Wong, Published: June 06, 2024,DOI: 10.7759/cureus.61855  Abstract Introduction Persistent olfactory dysfunction was seen in many patients upon coronavirus disease 2019 (COVID-19) infection recovery. However, research on its management was very limited, especially among the Southeast Asian population. Objectives We aim to investigate the role of olfactory rehabilitation and […]

Extending Paxlovid Not Effective Against Long COVID


Friday, 07 June 2024 Newsmax Health An extended course of the antiviral drug Paxlovid won’t ease a person’s long COVID symptoms, a new study finds. People who took Paxlovid for 15 days — three times as long as it’s prescribed for an initial COVID infection — had no better improvement in their long COVID than people taking a placebo, […]

People with long COVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies.


Findings from the largest UK study of patients hospitalized with SARS-CoV-2 infection show that long COVID leads to ongoing inflammation which can be detected in the blood. In an analysis of more than 650 people who had been hospitalized with severe COVID-19, patients with prolonged symptoms showed evidence of immune system activation. The exact pattern […]

Understanding long COVID: A call for better diagnosis and treatment


By Vijay Kumar Malesu,Mar 7 2024 In a recent review published in the journal Nature Reviews Microbiology, a group of authors summarized recent advancements in understanding long coronavirus disease (COVID) ‘s mechanisms, impacts, and research needs for better diagnostics and treatments. Review: Long COVID: major findings, mechanisms and recommendations Background Long COVID, affecting over 65 million globally, manifests through […]

Long COVID still has no cure — so these patients are turning to research


With key long COVID trials yet to yield results, people with the condition are trying to change how clinical trials are done. When Lisa McCorkell got COVID-19 in March 2020, her symptoms were mild. Her physicians told her to isolate from others and that she would recover in a few weeks. But the weeks stretched […]

Long COVID patients report improvements following self-regulation therapy, study finds


by University of California, Los Angeles A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies. The small-scale study, published in the Journal of Psychosomatic Research, recruited a group of 20 long COVID patients, many of whom had been experiencing symptoms for more than […]

Five Bold Predictions for Long COVID in 2024


Sara Novak, January 25, 2024 With a number of large-scale clinical trials underway and researchers on the hunt for new therapies, long COVID scientists are hopeful that this is the year patients — and doctors who care for them — will finally see improvements in treating their symptoms. Here are five bold predictions — all […]

Could new clues on how long COVID affects immune system lead to treatment?


By Deep Shukla on January 28, 2024 Medical News Today Approximately 10%-20%Trusted Source of individuals with a SARS-CoV-2 infection experience lingering symptoms beyond three months after symptom onset. These symptoms referred to as long COVID, can be debilitating, but there is a lack of diagnostic or therapeutic tools. A new study published in Science found that patients experiencing long COVID symptoms six months after […]

Clinical trial aims to find out if low-dose lithium could treat long COVID


By ELLEN GOLDBAUM Published January 11, 2023  “I just kept hearing the same story: that within days they were noticing satisfactory benefit. ” Thomas J. Guttuso Jr., professor, Department of Neurology, University of Buffalo Adults experiencing long COVID may be interested in a new University at Buffalo clinical trial that is testing low-dose lithium as a potential treatment. […]

Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients


Carlos Spuch, 1 ,* † Marta López-García, 1 , 2 , † Tania Rivera-Baltanás, 1 ,  , et.al. Front Pharmacol. 2022; 13: 850583. Published online 2022 Apr 14. doi:  10.3389/fphar.2022.850583PMCID: PMC9046673PMID: 35496309 Abstract At the beginning of the pandemic, we observed that lithium carbonate had a positive effect on the recovery of severely ill patients with COVID-19. Lithium is able to inhibit the replication of several types of […]